SCHEMBL6579740

SCHEMBL6579740

CCCCC(=O)c1c(-c2ccc3c(-c4ccccc4)c(OCC(=O)O)ccc3c2)oc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 6/20 0.46
KDM4E B2RXH2 5/20 0.42
GAA P10253 1/20 0.41
THRA P10827 2/20 0.41
THRB P10828 2/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 4/20 0.41
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ANO1 Q5XXA6 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580396 0.93 PTPN1 (0.45) PTPN1KDM4ETHRATHRBLMNA
SCHEMBL6582342 0.92 KDM4E (0.43) PTPN1KDM4EGAALMNAHTT
SCHEMBL6583890 0.90 PTPN1 (0.47) PTPN1KDM4EGAATHRATHRB
SCHEMBL6580117 0.90 PTPN1 (0.46) PTPN1KDM4EGAATHRATHRB
SCHEMBL6581487 0.90 PTPN1 (0.58) PTPN1KDM4EGAATHRATHRB
SCHEMBL6585755 0.90 PTPN1 (0.48) PTPN1KDM4EGAATHRATHRB
SCHEMBL6579760 0.89 LMNA (0.39) PTPN1KDM4ELMNAHTTALDH1A1
SCHEMBL6579471 0.85 LMNA (0.53) PTPN1KDM4ETHRATHRBLMNA
SCHEMBL6580209 0.84 KDM4E (0.40) PTPN1KDM4EGAALMNAHTT
SCHEMBL6584368 0.84 LMNA (0.35) PTPN1KDM4ELMNAHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401822-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) Wyeth (US) 2004-03-31 EP claimed
US-6599925-B2 Cardiovascular disorders; anticancer agents WYETH 2003-07-29 US claimed
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) WYETH 2003-01-23 US claimed
WO-2003000671-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH (US) 2003-01-03 WO claimed
EP-1401822-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) Wyeth (US) 2004-03-31 EP disclosed
US-6599925-B2 Cardiovascular disorders; anticancer agents WYETH 2003-07-29 US disclosed
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) WYETH 2003-01-23 US disclosed
WO-2003000671-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH (US) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) F2R, SERPINE1, SERPINC1 PTPN1 1287/4885KDM4E 4021/4885GAA 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.